Your browser doesn't support javascript.
loading
Evolution in the eligibility criteria of randomized controlled trials for systemic cancer therapies.
Srikanthan, A; Vera-Badillo, F; Ethier, J; Goldstein, R; Templeton, A J; Ocana, A; Seruga, B; Amir, E.
Afiliação
  • Srikanthan A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Department of Medicine, University of Toronto, 610 University Avenue, Toronto, Ontario M5G 2M9, Canada.
  • Vera-Badillo F; NCIC Clinical Trials Group and Department of Oncology, Queen's University, 10 Stuart Street, Kingston, Ontario K7L 3N6, Canada.
  • Ethier J; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Department of Medicine, University of Toronto, 610 University Avenue, Toronto, Ontario M5G 2M9, Canada.
  • Goldstein R; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Department of Medicine, University of Toronto, 610 University Avenue, Toronto, Ontario M5G 2M9, Canada.
  • Templeton AJ; Kantonsspital St. Gallen, Department of Medical Oncology, St. Gallen, Switzerland.
  • Ocana A; Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Edificio de Investigación, Calle Francisco Javier de Moya, 02006 Albacete, Spain.
  • Seruga B; Department of Medical Oncology, Institute of Oncology Ljubljana, Zaloska cesta 2, SI - 1000 Ljubljana, Slovenia.
  • Amir E; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Department of Medicine, University of Toronto, 610 University Avenue, Toronto, Ontario M5G 2M9, Canada. Electronic address: eitan.amir@uhn.ca.
Cancer Treat Rev ; 43: 67-73, 2016 Feb.
Article em En | MEDLINE | ID: mdl-26827694
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Ensaios Clínicos Controlados Aleatórios como Assunto / Definição da Elegibilidade / Neoplasias / Antineoplásicos Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Cancer Treat Rev Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Ensaios Clínicos Controlados Aleatórios como Assunto / Definição da Elegibilidade / Neoplasias / Antineoplásicos Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Cancer Treat Rev Ano de publicação: 2016 Tipo de documento: Article